BIMEKIZUMAB DEMONSTRATED SUSTAINED IMPROVEMENTS IN PAIN AND FATIGUE FOLLOWING EARLY CONTROL OF INFLAMMATION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS OVER 3 YEARS: RESULTS FROM 2 PHASE 3 STUDIES AND THEIR OPEN-LABEL EXTENSION

Bimzelx (bimekizumab-bkzx) - UCB

https://distribution-congress.eular.org/from.storage?image=15rRXWmdOAJ77zPlkD-rQhviQ4RfpdS3frjQGRZogl0QZ_r3IWDfDt7BPDPuodbk0

Victoria Navarro-Compán1; Sofia Ramiro 2, 3; Uta Kiltz4; Maureen Dubreuil5; Denis Poddubnyy6, 7, 8; Marina Magrey9; Atul Deodhar10; Sami Elmoufti11; Christine de la Loge12; Xenofon Baraliakos4

May 23, 2026